Sign in

CIK 0000875320

  • Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
043039129
Phone
+1 617-341-6393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,307,135
in 1 filing, $6.3M under 10b5-1 plans

Net −$6,307,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kewalramani Reshma −$6.3M CEO & President sold 12% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-12 Tatsis Ourania EVP, Chief Reg. & Quality Off. Grant or award +6,211 70,232
2025-02-12 LEIDEN JEFFREY M Executive Chairman Grant or award +7,209 32,617
2025-02-12 Sachdev Amit EVP Chief Patient & Ext Af Off Grant or award +6,211 76,802
2025-02-12 Kewalramani Reshma CEO & President Grant or award +19,015 135,933
2025-02-12 Bozic Carmen EVP and CMO Grant or award +5,546 42,853
2025-02-12 Biller Jonathan EVP and Chief Legal Officer Grant or award +4,437 20,767
2025-02-12 Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. Grant or award +6,211 29,436
2025-02-12 Arbuckle Stuart A EVP, COO Grant or award +7,903 77,446
2025-02-12 Ambrose Kristen SVP & Chief Accounting Officer Grant or award +2,080 12,033
2025-02-12 ALTSHULER DAVID EVP, Chief Scientific Officer Grant or award +5,324 48,423
2025-02-11 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale 10b5-1 −310 $459.83 $143K 64,021
2025-02-11 Biller Jonathan EVP and Chief Legal Officer Sale 10b5-1 −3,433 $459.87 $1.6M 16,330
2025-02-11 Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. Sale 10b5-1 −1,747 $459.83 $803K 23,225
2025-02-11 Ambrose Kristen SVP & Chief Accounting Officer Sale 10b5-1 −1,376 $459.83 $633K 9,953
2025-02-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Shares withheld for taxes −2,649 $467.98 $1.2M 58,879
2025-02-10 Tatsis Ourania EVP, Chief Reg. & Quality Off. Shares withheld for taxes 10b5-1 −2,143 $467.98 $1.0M 64,331
2025-02-10 Sachdev Amit EVP Chief Patient & Ext Af Off Shares withheld for taxes −2,056 $467.98 $962K 70,591
2025-02-10 Kewalramani Reshma CEO & President Shares withheld for taxes −8,300 $467.98 $3.9M 116,918
2025-02-10 Bozic Carmen EVP and CMO Shares withheld for taxes −2,142 $467.98 $1.0M 37,307
2025-02-10 Biller Jonathan EVP and Chief Legal Officer Shares withheld for taxes 10b5-1 −1,632 $467.98 $764K 19,763

Page 16 of 18 · 344 trades